Targeted Tyrosine Kinase Inhibitors And Advanced Hepatocellular Carcinoma
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Targeted Tyrosine Kinase Inhibitors And Advanced Hepatocellular Carcinoma

Targeted Tyrosine Kinase Inhibitors Used for the Management of Advanced Hepatocellular Carcinoma

Learning Objectives

  • Explain how recent HCC pathophysiologic findings have informed potential treatment targets
  • Review the clinical profiles of established and investigational systemic and targeted therapies, with a particular focus on tyrosine kinase inhibitors, for patients with advanced HCC
  • Design individualized management plans for sequencing treatment regimens for those with advanced HCC based on patient-specific characteristics

Download PowerPoint


Metadata